Species |
Human/Cynomolgus/Rhesus macaque |
Protein Construction |
ROR1(Gln30-Asp305) Accession # Q01973-1 |
His |
N-term |
C-term |
|
Purity |
> 95% as determined by Bis-Tris PAGE
> 95% as determined by HPLC |
Endotoxin Level |
Less than 1EU per μg by the LAL method. |
Biological Activity |
Immobilized ROR1 (30-305,Ig-like&Frizzled Domain), His, Human/Cynomolgus/Rhesus macaque (Cat.No.: Z03937) at 2 μg/ml (100μl/Well) on the plate can bind Anti-ROR1 Antibody, hFc Tag |
Expression System |
HEK293 |
Theoretical Molecular Weight |
31.90 kDa |
Apparent Molecular Weight |
Due to glycosylation, the protein migrates to 48-53 kDa based on Bis-Tris PAGE result. |
Formulation |
Lyophilized from a 0.22 μm filtered solution in PBS, pH 7.4 . |
Reconstitution |
It is recommended that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute the lyophilized powder in ddH2O more than 100 μg/ml. |
Storage & Stability |
Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles. |

ROR1 (30-305,Ig-like&Frizzled Domain), His, Human/Cynomolgus/Rhesus macaque on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.

The purity of ROR1 (30-305,Ig-like&Frizzled Domain), His, Human/Cynomolgus/Rhesus macaque is greater than 95% as determined by SEC-HPLC.

Immobilized ROR1 (30-305,Ig-like&Frizzled Domain), His, Human/Cynomolgus/Rhesus macaque at 2 μg/ml (100 μl/well) on the plate. Dose response curve for Anti-ROR1 Antibody, hFc Tag with the EC50 of 2.9 ng/ml determined by ELISA.
Synonyms |
ROR1; NTRKR1; dJ537F10.4 |
For laboratory research use only. Direct human use, including taking orally and injection and clinical use are forbidden.